@article{MAKHILLJAVA20181734555,
    title = {Isoflurane-Sparing Effect of Maropitant in Cats Undergoing
Ovariohysterectomy},
    journal = {Journal of Animal and Veterinary Advances},
    volume = {17},
    number = {3},
    pages = {82-86},
    year = {2018},
    issn = {1680-5593},
    doi = {javaa.2018.82.86},
    url = {https://makhillpublications.co/view-article.php?issn=1680-5593&doi=javaa.2018.82.86},
    author = {Kazuya,Kimiyoshi,Taro and},
    keywords = {Cat,isoflurane,laparotomy,maropitant,ovariohysterectomy,concentration,administered},
    abstract = {Maropitant exerts antiemetic effects and is also effective in reducing the inhalational anesthetic
requirement. In this study, 20 Japanese domestic cats that were brought to a private animal hospital to be
spayed were divided into two groups: one group was administered a combination of Maropitant and
Buprenorphine (MAR group, n = 10) and the other group was administered saline solution and buprenorphine
(control group, n = 10). In all cases, ovariohysterectomy was performed under general anesthesia using
isoflurane. The isoflurane concentration was measured in both groups at the following stages: at 15 min after
initiating inhalational anesthesia (T<sub>0</sub> ), during skin incision (T<sub>1</sub> ), left ovary retraction stimulation (T<sub>2</sub>), right ovary
retraction stimulation (T<sub>3</sub>), uterus retraction stimulation (T<sub>4</sub>), start of abdominal closure (T<sub>5</sub>) and start of skin suture (T<Sub>6</Sub>). The isoflurane requirements in the MAR group were significantly lower than those in the control group at T<sub>4</sub> -T<Sub>6</Sub> (p&lt;0.05) and the requirement decreased at T<Sub>6</Sub> by approximately 5.5%. 
These results suggest that maropitant might have an isoflurane-sparing effect in cats undergoing
ovariohysterectomy.}
    }